Alto Neuroscience (ANRO) Other Working Capital Changes (2023 - 2026)

Alto Neuroscience has disclosed Other Working Capital Changes across 4 years of filings, most recently posting $4.1 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $4.1 million, up 144.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (up 524.87% YoY), and the FY2025 annual result was -$101000.0, down 121.81% from the prior year.
• Other Working Capital Changes came in at $4.1 million for Q1 2026 at Alto Neuroscience, up from -$656000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.1 million in Q1 2026 to a low of -$744000.0 in Q3 2024.
• The 4-year median for Other Working Capital Changes is -$387000.0 (2023), against an average of $323153.8.
• Peak annual rise in Other Working Capital Changes reached 283.84% in 2024, while the deepest fall reached 1007.32% in 2024.
• Alto Neuroscience's Other Working Capital Changes stood at -$450000.0 in 2023, then changed by 0.0% to -$450000.0 in 2024, then slumped by 45.78% to -$656000.0 in 2025, then surged by 729.57% to $4.1 million in 2026.
• The last three Other Working Capital Changes figures came in at $4.1 million (Q1 2026), -$656000.0 (Q4 2025), and -$628000.0 (Q3 2025), per Business Quant data.